Podcasts about transcatheter

  • 85PODCASTS
  • 294EPISODES
  • 18mAVG DURATION
  • 1WEEKLY EPISODE
  • May 8, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about transcatheter

Latest podcast episodes about transcatheter

CTSNet To Go
The Beat With Joel Dunning Ep. 104: Future of Cardiothoracic Surgery

CTSNet To Go

Play Episode Listen Later May 8, 2025 61:40


This week on The Beat, CTSNet Editor-in-Chief Joel Dunning celebrates two years of the podcast and speaks with Dr. Joseph F. Sabik III, president of the Society of Thoracic Surgeons (STS) and chair of the Department of Surgery at University Hospitals Cleveland Medical Center, about the future of cardiothoracic surgery. Chapters 00:00 Intro 01:16 Dr. Sabik Guest 04:13 AATS 2025 20:26 Extended Sleeve Lobectomy Study 23:55 SQUAT Trial Results 26:28 TAVR vs SAVR in Women 27:49 Transition from Training to Practice 31:39 Totally Endoscopic Triple Valve 33:33 Redo AVR via Ministernotomy 35:18 ECMO Podcast Episode 37:19 Dr. Sabik, Future of CT Surgery 56:06 Upcoming Events 57:47 Closing They discuss the future of revascularization, advancements in valve procedures, arterial grafting, robotics training, and the importance of work-life balance. They also highlight the training of the next generation of surgeons, simulation-based education, and Dr. Sabik shares insights into the 62nd STS Annual Meeting. Additionally, Joel recaps the American Association for Thoracic Surgery (AATS) Annual Meeting emphasizing notable presentations and key insights from the event.   Joel also highlights recent JANS articles on extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer, neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable Stage III N2 NSCLC, transcatheter vs. surgical aortic valve replacement in women, and a guide for transition from cardiothoracic surgery training to practice.   In addition, Joel explores totally endoscopic triple valve surgery, redo aortic valve replacement through a ministernotomy, and a new podcast episode from Dr. Alice Copperwheat, “The Atrium: ECMO,” with expert guest Dr. Jose Fernandes. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Extended Sleeve Lobectomy After Neoadjuvant Immunochemotherapy for Centrally Located Non-Small Cell Lung Cancer  2.)  Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L)   3.) Transcatheter vs. Surgical Aortic Valve Replacement in Women: The RHEIA Trial  4.) A Guide for Transition from Cardiothoracic Surgery Training to Practice  CTSNET Content Mentioned  1.) Totally Endoscopic Triple Valve Surgery: AVR, MVr, TVr  2.) Redo Aortic Valve Replacement Through a Ministernotomy    3.) The Atrium: ECMO  Other Items Mentioned  1.) Webinar Series: Women in Cardiothoracic Surgery—Advancement Through Collaboration   2.) Endoscopic Cardiac Surgery Series: The Swiss Army Knife Approach  3.) Aortic Valve Replacement Series   4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

CTSNet To Go
The Beat With Joel Dunning Ep. 102: Endoscopic Cardiac Surgery

CTSNet To Go

Play Episode Listen Later Apr 24, 2025 44:42


This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. Mario Castillo-Sang, the Surgical Director of Mitral Valve and Heart Failure Therapies at St. Elizabeth Healthcare, Edgewood, Kentucky, USA, about totally endoscopic cardiac surgery. Chapters 00:00 Intro 01:17 Minimal Access Bedside Cardiac 04:37 Lung Cancer, Histological Subtype 09:29 TAVR vs SAVR, AS & CAD 12:22 Biopros TVR Outcomes 15:48 Mitral Annular Disjunction, MVR 18:47 Ozaki Technique, AV Reconst 20:46 Redo LVOT Reconst for Endocarditis 22:33 Totally Endoscopic ASD Closure TVR 24:08 Dr. Castillo-Sang, MI Bedside Endoscopy 40:51 Closing They explore key highlights from Dr. Castillo-Sang's CTSNet series Endoscopic Cardiac Surgery Series: The Swiss Army Knife Approach, his journey in performing endoscopic surgeries, and how he learned the techniques. Dr. Castillo-Sang shares the advantages of endoscopic surgery, as well as tips and recommendations for those wanting to learn this approach. He emphasizes the importance of the instruments he has worked with, detailing how these have improved over time. Additionally, they explore Dr. Castillo-Sang's involvement with the Endoscopic Cardiac Surgeons Club, discussing how he got involved and providing details about the club's upcoming annual meeting.   Joel also highlights recent JANS articles on the estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time, transcatheter vs surgical aortic valve replacement in Medicare beneficiaries with aortic stenosis and coronary artery disease, long-term outcomes after bioprosthetic tricuspid valve replacement, and outcomes of patients with mitral annular disjunction undergoing mitral valve repair.  In addition, Joel explores aortic valve reconstruction using the Ozaki technique, redo LVOT reconstruction for endocarditis, and totally endoscopic ASD closure with tricuspid valve repair. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study  2.) Transcatheter vs Surgical Aortic Valve Replacement in Medicare Beneficiaries With Aortic Stenosis and Coronary Artery Disease  3.) Long-Term Outcomes After Bioprosthetic Tricuspid Valve Replacement: A Multicenter Study  4.) Outcomes of Patients With Mitral Annular Disjunction Undergoing Mitral Valve Repair  CTSNET Content Mentioned  1.) Aortic Valve Reconstruction—The Ozaki Technique  2.) Redo LVOT Reconstruction for Endocarditis  3.) Totally Endoscopic ASD Closure With Tricuspid Valve Repair  Other Items Mentioned  1.) Endoscopic Cardiac Surgery Series: The Swiss Army Knife Approach  2.) Endoscopic Cardiac Surgeons Club  3.) Mini Heart Valves   4.) Aortic Valve Replacement Series     5.) Career Center 6.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

JACC Podcast
A Vascular Plug for Persistent Shock Following Transcatheter Mitral Valve Replacement | JACC

JACC Podcast

Play Episode Listen Later Apr 21, 2025 54:05


In this episode, Dr. Valentin Fuster dives into the complex and high-stakes world of cardiogenic shock, spotlighting new clinical trials, expert consensus guidance, and cutting-edge insights from machine learning. From evaluating the impact of intra-aortic balloon pumps to rethinking mechanical support strategies, the episode delivers a powerful update on one of cardiology's most urgent challenges.

JACC Podcast
LAVA-ECMO–Supported Dual-Transcatheter Aortic and Mitral Valve-in-Valve Replacement in Cardiogenic Shock | JACC

JACC Podcast

Play Episode Listen Later Apr 21, 2025 54:05


In this episode, Dr. Valentin Fuster dives into the complex and high-stakes world of cardiogenic shock, spotlighting new clinical trials, expert consensus guidance, and cutting-edge insights from machine learning. From evaluating the impact of intra-aortic balloon pumps to rethinking mechanical support strategies, the episode delivers a powerful update on one of cardiology's most urgent challenges.

JACC Podcast
5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis | JACC

JACC Podcast

Play Episode Listen Later Apr 14, 2025 10:19


In this podcast, Dr. Valentin Fuster reviews a pivotal study comparing the five-year outcomes of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in low-risk patients with severe aortic stenosis. The study found that both treatments yielded similar mortality and stroke rates, reinforcing TAVR's non-inferiority to surgery, though long-term outcomes in younger patients and the impact of pacemaker implantation remain areas of concern.

JACC Speciality Journals
Transcatheter Mechanical Aspiration of Right Ventricle Lead Vegetation | JACC: Case Reports | ACC.25

JACC Speciality Journals

Play Episode Listen Later Mar 27, 2025 15:22


Maurice Enriquez-Sarano, MD, FACC JACC: Case Reports Associate Editor, is joined by author Emmanuel Daniel, MD, discussing this study from Daniel et al presented at ACC.25 and published in JACC: Case Reports. Large lead-associated vegetations carry a significant risk of pulmonary embolism with hemodynamic instability when transvenous lead extraction is attempted. In this case, a 54-year-old male came to the hospital with fever and dyspnea. He was found to have MSSA bacteremia and a large RV lead vegetation on echo. He had multiple co-morbidities and was a high-risk surgical candidate. He underwent successful vegetation aspiration using the Flowtriever system, followed by endovascular lead extraction.

JACC Speciality Journals
Understanding the Effects of Mitral Transcatheter Edge-to-Edge Repair on Left Ventricular Function Using Pressure-Volume Loops | JACC: Advances

JACC Speciality Journals

Play Episode Listen Later Mar 26, 2025 2:32


Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Understanding the Effects of Mitral Transcatheter Edge-to-Edge Repair on Left Ventricular Function Using Pressure-Volume Loops

Medical Industry Feature
Novel Transcatheter Solution Approved for Tricuspid Regurgitation

Medical Industry Feature

Play Episode Listen Later Mar 14, 2025


Guest: Susheel Kodali, MD Susheel Kodali, MD, director of the Structural Heart and Valve Center at NewYork-Presbyterian and Columbia, shares more about an innovative transcatheter therapy for tricuspid regurgitation (TR), which is providing a new treatment option that vastly improves quality of life. Results from the TRISCEND II trial demonstrated the safety and efficacy of a tricuspid valve replacement system, which was fast-tracked for FDA approval due to its clear benefit for the vulnerable TR patient population. © 2025 NewYork-Presbyterian

JACC Podcast
Best Practices for Imaging of Transcatheter Valve Failure: An Update from the Heart Valve Collaboratory | JACC

JACC Podcast

Play Episode Listen Later Mar 10, 2025 6:46


In this podcast highlights the growing concern over transcatheter valve failure following transcatheter aortic valve replacement (TAVR), emphasizing the need for standardized imaging protocols and frequent follow-ups. Experts discuss best practices for monitoring and managing these patients, urging collaborative international efforts to validate new imaging techniques and improve patient outcomes.

JACC Podcast
Transcatheter vs Surgical Aortic Valve Replacement in Lower-Risk Patients: An Updated Meta-Analysis of Randomized Controlled Trials | JACC

JACC Podcast

Play Episode Listen Later Mar 3, 2025 72:25


In this episode, Dr. Valentin Fuster summarizes the March 11, 2025 issue of the JACC, which features groundbreaking research on transcatheter aortic valve replacement (TAVR) and its expanding applications. The podcast delves into the latest studies on TAVR's impact on heart failure patients, the need for better patient selection, and how new findings are shaping the future of aortic stenosis treatment.

JACC Speciality Journals
Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study - JACC: Advances

JACC Speciality Journals

Play Episode Listen Later Feb 26, 2025 2:30


Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study

CRTonline Podcast
Transcatheter Aortic Valve Repair for Aortic Regurgitation with the Cusper Device

CRTonline Podcast

Play Episode Listen Later Feb 25, 2025 8:31


Transcatheter Aortic Valve Repair for Aortic Regurgitation with the Cusper Device

SAGE Clinical Medicine & Research
JHVS: Assessment of Valve Hemodynamics Following Transcatheter Versus Surgical Aortic Valve Replacement in Women With Small Aortic Annulus

SAGE Clinical Medicine & Research

Play Episode Listen Later Feb 21, 2025 5:03


Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241296669

Dr. Baliga's Internal Medicine Podcasts
Continuation vs. Interruption of Oral Anticoagulation during Transcatheter Aortic Valve Implantation (TAVI)

Dr. Baliga's Internal Medicine Podcasts

Play Episode Listen Later Feb 12, 2025 2:31


The POPular PAUSE TAVI trial investigated whether continuing or interrupting oral anticoagulation during transcatheter aortic valve implantation (TAVI) affected clinical outcomes. The randomized, open-label, noninferiority study included 858 patients and assessed a composite primary outcome of cardiovascular death, stroke, myocardial infarction, major vascular complications, or major bleeding at 30 days. The trial found that continuation was not noninferior to interruption, with higher bleeding risk but no significant difference in thromboembolic events, supporting interruption of anticoagulation in high-bleeding-risk TAVI patients.

Dr. Baliga's Internal Medicine Podcasts
Transcatheter Aortic Valve Implantation (TAVI) and FFR-Guided PCI vs. Surgical AVR and CABG in Severe Aortic Stenosis with Complex CAD

Dr. Baliga's Internal Medicine Podcasts

Play Episode Listen Later Feb 11, 2025 2:54


The TCW Trial compared TAVI + FFR-guided PCI versus SAVR + CABG in patients with severe aortic stenosis and complex coronary artery disease. This multicenter, randomized controlled trial included 172 patients aged ≥70 years. At 1 year, the primary composite endpoint (death, MI, stroke, revascularization, valve reintervention, or major bleeding) was significantly lower in the TAVI + PCI group (4%) compared to SAVR + CABG (23%), meeting both noninferiority and superiority criteria. The study suggests TAVI + PCI as a safer, less invasive alternative with reduced mortality and bleeding risks in selected patients.

JACC Speciality Journals
JACC: Asia - Brief Introduction - Effect of Renal Impairment on Clinical Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair

JACC Speciality Journals

Play Episode Listen Later Feb 11, 2025 1:51


JACC Speciality Journals
JACC: Asia - Brief Introduction - Extremely Small 20-mm Versus Standard-Size Balloon-Expandable Transcatheter Heart Valves: Propensity-Matched Analysis From the OCEAN-TAVI Registry

JACC Speciality Journals

Play Episode Listen Later Feb 11, 2025 2:19


CRTonline Podcast
TRISCEND II: Randomized Comparison of Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

CRTonline Podcast

Play Episode Listen Later Jan 21, 2025 27:33


TRISCEND II: Randomized Comparison of Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

JACC Podcast
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

JACC Podcast
Advances in Transcatheter Tricuspid Valve Interventions: Implications for Health Policy

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

JACC Podcast
Transcatheter Interventions in Tricuspid Regurgitation: Shifting the Focus Beyond Quantity of Life to Quality of Life

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

JACC Podcast
Transcatheter Tricuspid Valve Replacement

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

JACC Podcast
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-Year Outcomes From the TRILUMINATE Randomized Cohort

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

JACC Podcast
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry

JACC Podcast

Play Episode Listen Later Jan 20, 2025 73:57


Introduction (00:00 - 03:00) Dr. Valentin Fuster introduces the focus of the January 28, 2025, issue of JACC on transcatheter tricuspid valve interventions. He emphasizes the growing importance of addressing symptomatic tricuspid regurgitation, a major predictor of morbidity and mortality, and explores potential treatments that aim to improve quality of life and decrease hospitalizations. Transcatheter Tricuspid Valve Repair (03:00 - 20:30) Fuster discusses two key studies: the TRILUMINATE randomized trial and a large European registry. While the TRILUMINATE trial demonstrated significant quality of life improvements using the TriClip device, it did not show a reduction in mortality or heart failure hospitalizations, suggesting the need for longer follow-up in future studies. Meanwhile, the European registry highlights the effectiveness of the Pascal device, showing significant symptomatic improvements and tricuspid regurgitation reduction in high-risk patients. Transcatheter Tricuspid Valve Replacement (20:30 - 35:00) Fuster moves on to discuss the TRISCEND II pivotal trial on transcatheter tricuspid valve replacement. Like the previous repair methods, it primarily improves health status without significantly reducing mortality or hospitalizations, as shown in the trial's findings. He also mentions an excellent state-of-the-art review on this intervention featured in JACC. Imaging in Transcatheter Valve Interventions (35:00 - 45:00) This section highlights the importance of imaging in transcatheter valve interventions. Fuster presents a new project under the leadership of Dr. Kalyanam Shivkumar, aimed at enhancing cardiac anatomy and function resources, supporting advancements in cardiovascular treatments. Conclusion (45:00 - 55:00) Dr. Valentin Fuster wraps up the podcast by summarizing the key takeaways: while current transcatheter interventions show promise in improving symptoms and quality of life for patients with severe tricuspid regurgitation, long-term follow-up is crucial to fully understand their impact on survival and heart failure hospitalizations.

CRTonline Podcast
ACCESS TAVI: Randomized Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation

CRTonline Podcast

Play Episode Listen Later Jan 14, 2025 11:09


ACCESS TAVI: Randomized Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation

CRTonline Podcast
CLASP IID 2 Year: RCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

CRTonline Podcast

Play Episode Listen Later Dec 31, 2024 17:50


CLASP IID 2 Year: RCT and Registry: Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation

JACC Podcast
Impact of Renal & Liver Function on Clinical Outcomes Following Tricuspid Valve Transcatheter Edge-to-Edge Repair

JACC Podcast

Play Episode Listen Later Dec 9, 2024 11:16


In this podcast, Dr. Valentin Fuster discusses a study on the impact of renal and liver function on clinical outcomes following tricuspid valve transcatheter H2O repair in patients with severe tricuspid regurgitation. While the study found no significant differences in organ function between repair and control groups at 12 months, successful repairs showed small but favorable improvements in kidney and liver function, suggesting potential long-term benefits in reducing heart failure hospitalizations and mortality.

The Incubator
#262 - [Journal Club Shorts] -

The Incubator

Play Episode Listen Later Dec 8, 2024 10:41


Send us a textTranscatheter and Surgical Ductus Arteriosus Closure in Very Low Birth Weight Infants: 2018-2022.Leahy BF, Edwards EM, Ehret DEY, Soll RF, Yeager SB, Flyer JN.Pediatrics. 2024 Aug 1;154(2):e2024065905. doi: 10.1542/peds.2024-065905.PMID: 39005106As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

JACC Speciality Journals
JACC: Asia - Brief Introduction - Asian Pacific Society of Cardiology Position Statement on the Use of Transcatheter Aortic Valve Implantation in the Management of Aortic Stenosis

JACC Speciality Journals

Play Episode Listen Later Dec 3, 2024 1:18


JACC Podcast
Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-analysis of Randomized Controlled Trials

JACC Podcast

Play Episode Listen Later Dec 2, 2024 31:40


In this episode, Dr. Valentin Fuster delves into the latest research surrounding the use of the mitral clip for patients with severe functional mitral regurgitation, comparing the results of three major trials: the French MITRA-FR trial, the American COAPT trial, and the Reshape HF 2 trial. While the COAPT and Reshape HF 2 trials show positive outcomes, especially in reducing hospitalizations and improving heart failure symptoms, the French trial saw no benefit, prompting debate over the influence of left ventricular volume and disease severity on treatment success, with expert opinions calling for further studies and individualized meta-analyses.

CRTonline Podcast
NOTION-3 – Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation

CRTonline Podcast

Play Episode Listen Later Nov 7, 2024 19:26


NOTION-3 – Percutaneous Coronary Intervention in Patients Undergoing Transcatheter Aortic Valve Implantation

CRTonline Podcast
MATTERHORN – Transcatheter Versus Surgical Mitral Valve Repair in Patients With Heart Failure and Secondary Mitral Regurgitation

CRTonline Podcast

Play Episode Listen Later Nov 5, 2024 20:48


MATTERHORN – Transcatheter Versus Surgical Mitral Valve Repair in Patients With Heart Failure and Secondary Mitral Regurgitation

JACC Speciality Journals
JACC: Asia - Brief Introduction - 1-Year Outcomes of Fourth-Generation Mitral Transcatheter Edge-to-Edge Repair in Japan From the EXPAND G4 Study

JACC Speciality Journals

Play Episode Listen Later Nov 5, 2024 1:11


In this episode of the JACC: Asia podcast, Editor-in-Chief Jian'an Wang examines the EXPAND G4 study and evaluates the one-year outcomes of the first-generation Edge-to-Edge mitral valve repair device in 95 Japanese patients, demonstrating a 100% implantation success rate and significant improvements in mitral regurgitation severity and functional capacity. These promising results underscore the potential of this device to deliver excellent clinical outcomes for Asian patients with mitral valve disease.

Pediheart: Pediatric Cardiology Today
Pediheart Podcast #317: Transcatheter Pulmonary Valve Replacement After The Arterial Switch Operation

Pediheart: Pediatric Cardiology Today

Play Episode Listen Later Nov 1, 2024 27:52


Pulmonary valve replacement following the arterial switch operation is rare. However, when necessary, how do techniques of transcatheter valve replacement fare for this indication? Why would average outcomes in this setting be less good than in the typical TPVR tetralogy of Fallot patient? How does the presence of stents in the pulmonary arteries in this patient group affect candidacy for TPVR? Are there ways to predict who might be a candidate for a TPVR vs. surgical PVR before coming to the catheterization lab? These are amongst the questions reviewed and posed to Dr. Stephen Nageotte who is the director of the cardiac catheterization laboratory at Loma Linda Children's Hospital in Loma Linda, California.  DOI: 10.1002/ccd.31152

Saving Lives: Critical Care w/eddyjoemd
Severe Tricuspid Regurgitation Treatment: Transcatheter Tricuspid-Valve Replacement (TRISCEND II)

Saving Lives: Critical Care w/eddyjoemd

Play Episode Listen Later Oct 31, 2024 9:23


In this episode of the Saving Lives Podcast, Eddy Joe explores the TRISCEND II trial's groundbreaking findings on transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. Learn about the quality-of-life improvements, procedural risks, and future directions for this innovative therapy. The Vasopressor & Inotrope HandbookAmazon: https://amzn.to/3UvFFVf (affiliate link) Signed Copy: https://eddyjoemd.myshopify.com/products/the-vasopressor-inotrope-handbook Citation: https://www.nejm.org/doi/full/10.1056/NEJMoa2401918 --- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support

JACC Podcast
Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial

JACC Podcast

Play Episode Listen Later Oct 30, 2024 10:51


In this episode of JACC, Author Suzanne Arnold, MD and JACC Associate Editor Dennis T. Ko, MD, discusses groundbreaking findings from the Tricatin-2 trial, the first clinical study on transcatheter tricuspid valve replacement. The results reveal significant improvements in quality of life for patients, particularly those with severe tricuspid regurgitation, highlighting the transformative potential of this procedure compared to traditional medical therapy.

JACC Podcast
Transcatheter Valve Repair for Tricuspid Regurgitation: 1-Year Results From a Large European Real-World Registry

JACC Podcast

Play Episode Listen Later Oct 27, 2024 14:32


Author Joerg Hausleiter, MD and Executive Associate Editor Aakriti Gupta, MD, FACC. discuss the TAVR UNLOAD trial, which focused on patients with moderate aortic stenosis (AS) and reduced ejection fraction (HFrEF). The trial found no significant difference in the primary endpoint (composite of mortality, stroke, and hospitalizations) between the TAVR and clinical surveillance groups. However, patients who underwent TAVR showed a significant improvement in quality of life at one year. The conversation highlighted the need for individualized treatment approaches, emphasizing patient selection, while also considering trial limitations, including slow enrollment and study size.

JACC Podcast
Tricuspid Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: 1-year Outcomes From the TRILUMINATE Randomized Cohort

JACC Podcast

Play Episode Listen Later Oct 27, 2024 2:48


JACC Associate Editor Celina M. Yong, MD, FACC, and JACC: Case Reports Editor in Chief Gilbert H. L. Tang, MD, MSc, MBA, FACC, discuss this paper published in JACC and presented at TCT. TRILUMINATE Pivotal is the first randomized, controlled trial evaluating transcatheter edge-to-edge repair (T-TEER) for severe tricuspid regurgitation (TR). Adaptive design randomized 572 subjects in the primary or subsequent cohorts. Subjects were elderly with atrial fibrillation and prior HFH. Primary endpoint was met at 1 year with a larger win ratio for T-TEER driven by KCCQ improvement with no significant differences in mortality and tricuspid valve surgery or HFH.

JACC Speciality Journals
JACC: Advances - Lipoprotein(a) Levels in Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation Compared to Controls

JACC Speciality Journals

Play Episode Listen Later Oct 24, 2024 2:32


Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on lipoprotein(a) levels in severe aortic stenosis referred for transcatheter aortic valve implantation compared to controls.

The Medical Journal of Australia
Episode 567: MJA Podcasts 2024 Episode 26: Transcatheter aortic valve implantation

The Medical Journal of Australia

Play Episode Listen Later Oct 6, 2024 15:59


 Today we are discussing transcatheter aortic valve implantation, also known as TAVI.  TAVI that has become pivotal in the cardiology space since its introduction in 2002, and today we'll compare TAVI to surgical aortic valve replacement. We'll also discuss the importance of shared decision making.  This podcast is sponsored by Medtronic. The views expressed in this podcast are not necessarily those of Medtronic.  To learn more, we are joined by consultant cardiologists Dr Jason Sharp & Dr Dennis Wang from the Sydney Adventist Hospital to discuss some key updates in the TAVI space.

BackTable Podcast
Ep. 481 Genicular Artery Embolization: How I Do It with Dr. Osman Ahmed

BackTable Podcast

Play Episode Listen Later Sep 20, 2024 37:30


Genicular artery embolization (GAE) is quickly emerging as a treatment option for knee osteoarthritis when other therapies have failed. In this episode of the BackTable Podcast, Dr. Osman Ahmed discusses the origins of GAE and how he employs it in his practice. --- CHECK OUT OUR SPONSOR Guerbet https://www.guerbet-us.com --- SYNPOSIS Dr. Ahmed, an interventional radiologist at the University of Chicago, shares details about the procedure, his journey in adopting it, and his thoughts on the current landscape of GAE. Topics include procedural techniques, patient selection, anatomical considerations, potential complications, and the importance of ongoing research in this field. --- TIMESTAMPS 00:00 - Introduction 04:43 - Knee Osteoarthritis and Current Treatments 07:54 - Building a GAE Practice 13:23 - Tools and Procedure: Step-by-Step 25:05 - Post-Procedure Care and Complications 30:26 - Future of GAE and Other Applications 34:03 - Conclusion and Contact Information --- RESOURCES BackTable INN Ep. 46- New Innovations in Treatment of PE: The Flow Medical Story with Founders Dr. Osman Ahmed and Dr. Jonathan Paul: https://www.backtable.com/shows/innovation/podcasts/46/new-innovations-in-treatment-of-pe-the-flow-medical-story BackTable VI Ep. 429- Tackling Upper GI Bleeds: Techniques and Tools with Dr. Osman Ahmed: https://www.backtable.com/shows/vi/podcasts/429/tackling-upper-gi-bleeds-techniques-tools BackTable VI Ep. 447- Exploring GAE: Clinical Insights & Outcomes with Dr. Mark Little: https://www.backtable.com/shows/vi/podcasts/447/exploring-gae-clinical-insights-outcomes GEST MSK Conference 2025 (Paris): https://www.gestmsk.com/ Okuno Y et al. Transcatheter arterial embolization as a treatment for medial knee pain in patients with mild to moderate osteoarthritis (2014): https://pubmed.ncbi.nlm.nih.gov/24993956/ Little MW et al. Genicular artEry embolizatioN in patiEnts with oSteoarthrItiS of the Knee (GENESIS 1) Using Permanent Microspheres: Interim Analysis (2021): https://pubmed.ncbi.nlm.nih.gov/33474601/ Little MW et al. Genicular Artery Embolisation in Patients with Osteoarthritis of the Knee (GENESIS 2): Protocol for a Double-Blind Randomised Sham-Controlled Trial (2023): https://pubmed.ncbi.nlm.nih.gov/37337060/ Correa MP et al.GAUCHO - Trial Genicular Artery Embolization Using Imipenem/Cilastatin vs. Microsphere for Knee Osteoarthritis: A Randomized Controlled Trial (2022): https://pubmed.ncbi.nlm.nih.gov/35304614/ Sapoval M et al. Genicular artery embolization for knee osteoarthritis: Results of the LipioJoint-1 trial (2024): https://pubmed.ncbi.nlm.nih.gov/38102013/

Becker’s Healthcare Podcast
Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institute

Becker’s Healthcare Podcast

Play Episode Listen Later Sep 18, 2024 10:27


In this episode, Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institute and a registered yoga teacher, discusses the evolving landscape of cardiology, the challenges of talent retention, and the importance of addressing physician burnout.

Becker’s Healthcare -- Ambulatory Surgery Centers Podcast
Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institute

Becker’s Healthcare -- Ambulatory Surgery Centers Podcast

Play Episode Listen Later Sep 18, 2024 10:27


In this episode, Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institute and a registered yoga teacher, discusses the evolving landscape of cardiology, the challenges of talent retention, and the importance of addressing physician burnout.

Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institut

Becker’s Healthcare -- Spine and Orthopedic Podcast

Play Episode Listen Later Sep 18, 2024 10:27


In this episode, Dr. Mario Gössl, Director of Transcatheter Valve Therapies at Allina Health Minneapolis Heart Institute and a registered yoga teacher, discusses the evolving landscape of cardiology, the challenges of talent retention, and the importance of addressing physician burnout.

New England Journal of Medicine Interviews
NEJM at ESC — Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation

New England Journal of Medicine Interviews

Play Episode Listen Later Aug 30, 2024 3:26


Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

New England Journal of Medicine Interviews
NEJM at ESC — Transcatheter Repair versus Surgery for Secondary Mitral Regurgitation

New England Journal of Medicine Interviews

Play Episode Listen Later Aug 30, 2024 3:32


Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

New England Journal of Medicine Interviews
NEJM at ESC — PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation

New England Journal of Medicine Interviews

Play Episode Listen Later Aug 30, 2024 4:01


Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.

JACC Podcast
Treatment of Transcatheter Aortic Valve Thrombosis: JACC Review Topic of the Week

JACC Podcast

Play Episode Listen Later Aug 19, 2024 9:07


Dr. Valentin Fuster discusses the treatment and diagnosis of transcatheter aortic valve thrombosis, focusing on its manifestations, diagnostic techniques using multi-slice computed tomography, and a proposed treatment algorithm. It highlights the difference between subclinical and clinical thrombosis and provides a detailed approach to managing both, including antiplatelet and anticoagulant therapies.

The Incubator
#232 - [Journal Club Shorts] -

The Incubator

Play Episode Listen Later Aug 11, 2024 7:52


Send us a Text Message.Transcatheter and Surgical Ductus Arteriosus Closure in Very Low Birth Weight Infants: 2018-2022.Leahy BF, Edwards EM, Ehret DEY, Soll RF, Yeager SB, Flyer JN.Pediatrics. 2024 Jul 15:e2024065905. doi: 10.1542/peds.2024-065905. Online ahead of print.PMID: 39005106As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

The Incubator
#232 - [Journal Club Shorts] -

The Incubator

Play Episode Listen Later Aug 11, 2024 8:21


Send us a Text Message.Long term follow-up of patients with patent ductus arteriosus after transcatheter closure.Peng Y, Cheng Z, Zhang Y, Yi Q.Pediatr Res. 2024 Jun 14. doi: 10.1038/s41390-024-03317-x. Online ahead of print.PMID: 38877281As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!